Newsroom
To Get in Touch with DLC:
Media (@) Diabetes Leadership (DOT) org
Hot Topics
In The News
Release
Centers for Medicare and Medicaid Services (CMS) and Competitive Bidding
Letter
DLC & DPAC Comment on Diabetes Caucus Insulin Framework
Release
DLC Urges Congress To Support The Special Diabetes Program
Release
Statement on President Biden's Agenda to Reduce Prescription Drug Prices
Report
Medicare Part D (Prescription Drug) Plans May Now Cover Omnipod®
Letter
Blood Glucose Monitor Accuracy
Letter
Sharps Disposal
Release
DLC & DPAC Comment on Medicare CGM Coverage
Report
Test Strip Contamination In Multi-Patient Settings
Release
Diabetes community urges equal T1D & T2D vaccine priority
Release
The Diabetes Leadership Council Recognizes Three Congressional Leaders as Diabetes Champions
DLC and DPAC Joint Statement on the FTC’s Case Against Pharmacy Benefit Managers (PBMs)
Report
Consensus Statement: Towards the standardisation of adult person-reported outcome domains in diabetes research
Letter
DLC and DPAC issue joint statement on Tennessee decision to reject legislation that would cap insulin costs
Release
Victory For Patients Reiterated - Court Makes it Clear: Rule Requiring Copay Assistance to Count Now in Effect
Release
Court Strikes Down HHS Rule that Allowed Insurers to Not Count Copay Assistance
Release
Sanofi Joins Lilly, Novo in Reducing Certain Insulin Prices
Release
Novo Nordisk Latest to Limit Cost-Sharing for People with Diabetes
Statements and Letters
Fast Facts
Policy Recommendations to Improve U.S. Health Care
Patient costs for medicines, equipment and supplies should reflect all discounts and rebates negotiated or mandated across the supply chain, just like other health care products and services. National level rebate reform is a critical step to help patients afford their medicines and confront perverse financial incentives in the current system.
Download Our Consensus Statement